Pandemrix

Nchi: Umoja wa Ulaya

Lugha: Kiingereza

Chanzo: EMA (European Medicines Agency)

Nunua Sasa

Taarifa za kipeperushi Taarifa za kipeperushi (PIL)
10-06-2016
Tabia za bidhaa Tabia za bidhaa (SPC)
10-06-2016
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma (PAR)
10-06-2016

Viambatanisho vya kazi:

split influenza virus inactivated, containing antigen equivalent to A/California/07/2009 (H1N1)-derived strain used NYMC X-179A

Inapatikana kutoka:

GlaxoSmithKline Biologicals S.A.

ATC kanuni:

J07BB02

INN (Jina la Kimataifa):

influenza vaccine (H1N1)v (split virion, inactivated, adjuvanted)

Kundi la matibabu:

Influenza vaccines

Eneo la matibabu:

Influenza, Human; Immunization; Disease Outbreaks

Matibabu dalili:

Prophylaxis of influenza caused by A (H1N1)v 2009 virus. Pandemrix should only be used if the recommended annual seasonal trivalent / quadrivalent influenza vaccines are not available and if immunisation against (H1N1)v is considered necessary (see sections 4.4 and 4.8).Pandemrix should be used in accordance with Official Guidance.

Bidhaa muhtasari:

Revision: 23

Idhini hali ya:

Withdrawn

Idhini ya tarehe:

2008-05-20

Taarifa za kipeperushi

                                35
B. PACKAGE LEAFLET
36
PACKAGE LEAFLET: INFORMATION FOR THE USER
PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION
Influenza vaccine (H1N1)v (split virion, inactivated, adjuvanted)
This medicine is subject to additional monitoring. This will allow
quick identification of new safety
information. You can help by reporting any side effects you may get.
See the end of section 4 for how to
report side effects.
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU RECEIVE THIS VACCINE
BECAUSE IT CONTAINS IMPORTANT
INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or nurse.
-
This vaccine has been prescribed for you only. Do not pass it on to
others.
-
If you get any of side effects, talk to your doctor. This includes any
possible side effects not listed
in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET:
1.
What Pandemrix is and what it is used for
2.
What you need to know before you receive Pandemrix
3.
How Pandemrix is given
4.
Possible side effects
5.
How to store Pandemrix
6.
Contents of the pack and other information
1.
WHAT PANDEMRIX IS AND WHAT IT IS USED FOR
WHAT PANDEMRIX IS AND WHAT IT IS USED FOR
Pandemrix is a vaccine to prevent influenza (flu) caused by A(H1N1)v
2009 virus.
Your doctor will normally recommend a different vaccine (annual
trivalent/quadrivalent influenza
vaccine) instead of Pandemrix, but if the trivalent/quadrivalent
vaccines are not available Pandemrix may
still be an option if you need protection against A(H1N1)v influenza
(see Take special care with
Pandemrix).
HOW PANDEMRIX WORKS
When a person is given the vaccine, the immune system (the body’s
natural defence system) will produce
its own protection (antibodies) against the disease. None of the
ingredients in the vaccine can cause flu.
2.
WHAT YOU NEED TO KNOW BEFORE YOU RECEIVE PANDEMRIX
PANDEMRIX SHOULD NOT BE GIVEN:
•
if you have previously had a sudden life-threatening allergic reaction
to any ingredient of this
vaccine (listed in section 6) or
                                
                                Soma hati kamili

Tabia za bidhaa

                                1
ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
2
This medicinal product is subject to additional monitoring. This will
allow quick identification of new
safety information. Healthcare professionals are asked to report any
suspected adverse reactions. See
section 4.8 for how to report adverse reactions.
1.
NAME OF THE MEDICINAL PRODUCT
Pandemrix suspension and emulsion for emulsion for injection.
Influenza vaccine (H1N1)v (split virion, inactivated, adjuvanted)
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
After mixing, 1 dose (0.5 ml) contains:
Split influenza virus, inactivated, containing antigen
*
equivalent to:
_ _
A/California/07/2009 (H1N1) derived strain used NYMC X-179A
3.75 micrograms
**
*
propagated in eggs
**
haemagglutinin
AS03 adjuvant composed of squalene (10.69 milligrams), DL-
α
-tocopherol (11.86 milligrams) and
polysorbate 80 (4.86 milligrams)
The suspension and emulsion, once mixed, form a multidose vaccine in a
vial. See section 6.5 for the
number of doses per vial.
Excipient with known effect
The vaccine contains 5 micrograms thiomersal
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Suspension and emulsion for emulsion for injection.
The suspension is a colourless light opalescent liquid.
The emulsion is a whitish to yellowish homogeneous milky liquid.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Prophylaxis of influenza caused by A (H1N1)v 2009 virus. Pandemrix
should only be used if the
recommended annual seasonal trivalent/quadrivalent influenza vaccines
are not available and if
immunisation against (H1N1)v is considered necessary (see sections 4.4
and 4.8).
Pandemrix should be used in accordance with Official Guidance.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
3
The dose recommendations take into account the safety and
immunogenicity data from clinical studies in
healthy subjects
See sections 4.4, 4.8 and 5.1 for details.
No data are available in children aged less than 6 months.
_Adults aged 18 years and older: _
One dose of 0.5 ml at an elected dat
                                
                                Soma hati kamili

Bidhaa zinazofanana

Viambatanisho vya kazi split influenza virus inactivated, containing antigen equivalent to A/California/07/2009 (H1N1)-derived strain used NYMC X-179A

split influenza virus inactivated, containing antigen equivalent to A/California/07/2009 (H1N1)-derived strain used NYMC X-179A

ATC kanuni J07BB02

J07BB02

Mzalishaji au wazalishaji wadogowadogo GlaxoSmithKline Biologicals S.A.

GlaxoSmithKline Biologicals S.A.

INN (Jina la Kimataifa) influenza vaccine (H1N1)v (split virion, inactivated, adjuvanted)

influenza vaccine (H1N1)v (split virion, inactivated, adjuvanted)

Nyaraka katika lugha zingine

Taarifa za kipeperushi Taarifa za kipeperushi Kibulgaria 10-06-2016
Tabia za bidhaa Tabia za bidhaa Kibulgaria 10-06-2016
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kibulgaria 10-06-2016
Taarifa za kipeperushi Taarifa za kipeperushi Kihispania 10-06-2016
Tabia za bidhaa Tabia za bidhaa Kihispania 10-06-2016
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kihispania 10-06-2016
Taarifa za kipeperushi Taarifa za kipeperushi Kicheki 10-06-2016
Tabia za bidhaa Tabia za bidhaa Kicheki 10-06-2016
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kicheki 10-06-2016
Taarifa za kipeperushi Taarifa za kipeperushi Kidenmaki 10-06-2016
Tabia za bidhaa Tabia za bidhaa Kidenmaki 10-06-2016
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kidenmaki 10-06-2016
Taarifa za kipeperushi Taarifa za kipeperushi Kijerumani 10-06-2016
Tabia za bidhaa Tabia za bidhaa Kijerumani 10-06-2016
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kijerumani 10-06-2016
Taarifa za kipeperushi Taarifa za kipeperushi Kiestonia 10-06-2016
Tabia za bidhaa Tabia za bidhaa Kiestonia 10-06-2016
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kiestonia 10-06-2016
Taarifa za kipeperushi Taarifa za kipeperushi Kigiriki 10-06-2016
Tabia za bidhaa Tabia za bidhaa Kigiriki 10-06-2016
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kigiriki 10-06-2016
Taarifa za kipeperushi Taarifa za kipeperushi Kifaransa 10-06-2016
Tabia za bidhaa Tabia za bidhaa Kifaransa 10-06-2016
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kifaransa 10-06-2016
Taarifa za kipeperushi Taarifa za kipeperushi Kiitaliano 10-06-2016
Tabia za bidhaa Tabia za bidhaa Kiitaliano 10-06-2016
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kiitaliano 10-06-2016
Taarifa za kipeperushi Taarifa za kipeperushi Kilatvia 10-06-2016
Tabia za bidhaa Tabia za bidhaa Kilatvia 10-06-2016
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kilatvia 10-06-2016
Taarifa za kipeperushi Taarifa za kipeperushi Kilithuania 10-06-2016
Tabia za bidhaa Tabia za bidhaa Kilithuania 10-06-2016
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kilithuania 10-06-2016
Taarifa za kipeperushi Taarifa za kipeperushi Kihungari 10-06-2016
Tabia za bidhaa Tabia za bidhaa Kihungari 10-06-2016
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kihungari 10-06-2016
Taarifa za kipeperushi Taarifa za kipeperushi Kimalta 10-06-2016
Tabia za bidhaa Tabia za bidhaa Kimalta 10-06-2016
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kimalta 10-06-2016
Taarifa za kipeperushi Taarifa za kipeperushi Kiholanzi 10-06-2016
Tabia za bidhaa Tabia za bidhaa Kiholanzi 10-06-2016
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kiholanzi 10-06-2016
Taarifa za kipeperushi Taarifa za kipeperushi Kipolandi 10-06-2016
Tabia za bidhaa Tabia za bidhaa Kipolandi 10-06-2016
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kipolandi 10-06-2016
Taarifa za kipeperushi Taarifa za kipeperushi Kireno 10-06-2016
Tabia za bidhaa Tabia za bidhaa Kireno 10-06-2016
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kireno 10-06-2016
Taarifa za kipeperushi Taarifa za kipeperushi Kiromania 10-06-2016
Tabia za bidhaa Tabia za bidhaa Kiromania 10-06-2016
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kiromania 10-06-2016
Taarifa za kipeperushi Taarifa za kipeperushi Kislovakia 10-06-2016
Tabia za bidhaa Tabia za bidhaa Kislovakia 10-06-2016
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kislovakia 10-06-2016
Taarifa za kipeperushi Taarifa za kipeperushi Kislovenia 10-06-2016
Tabia za bidhaa Tabia za bidhaa Kislovenia 10-06-2016
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kislovenia 10-06-2016
Taarifa za kipeperushi Taarifa za kipeperushi Kifinlandi 10-06-2016
Tabia za bidhaa Tabia za bidhaa Kifinlandi 10-06-2016
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kifinlandi 10-06-2016
Taarifa za kipeperushi Taarifa za kipeperushi Kiswidi 10-06-2016
Tabia za bidhaa Tabia za bidhaa Kiswidi 10-06-2016
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kiswidi 10-06-2016
Taarifa za kipeperushi Taarifa za kipeperushi Kinorwe 10-06-2016
Tabia za bidhaa Tabia za bidhaa Kinorwe 10-06-2016
Taarifa za kipeperushi Taarifa za kipeperushi Kiaisilandi 10-06-2016
Tabia za bidhaa Tabia za bidhaa Kiaisilandi 10-06-2016
Taarifa za kipeperushi Taarifa za kipeperushi Kroeshia 10-06-2016
Tabia za bidhaa Tabia za bidhaa Kroeshia 10-06-2016
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kroeshia 10-06-2016

Tafuta arifu zinazohusiana na bidhaa hii

Taadhari Pandemrix split influenza virus inactivated, vaccine

Pandemrix split influenza virus inactivated, vaccine

Tazama historia ya hati

Historia ya nyaraka Historia ya nyaraka

Pandemrix